Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 43%
Hold 14%
Sell 7%
Strong Sell 0%

Bulls say

Colgate-Palmolive's advertising expenditure as a percentage of sales has experienced a notable increase from 11.6% in 2021 to 13.5% in 2024, indicating a commitment to enhancing brand visibility and market presence. Furthermore, the company successfully achieved growth in both price and volume from the second quarter of 2023 through the third quarter of 2024, reflecting strong consumer demand and operational effectiveness. With a diverse product portfolio and approximately 70% of its sales generated from international markets, including 45% from emerging regions, Colgate-Palmolive is well-positioned for sustained growth in the global household and personal care industry.

Bears say

Colgate-Palmolive experienced a decline in gross margin of 75 basis points year-over-year in the second quarter of 2025, attributed to raw material inflation and tariffs, indicating potential pressure on profitability. In addition, the company reported volume declines of 0.3% and 0.9% in the first and second quarters of 2025, respectively, despite achieving positive price growth during the same periods. The dog food category, which represents a significant segment of their offerings through Hill's, has also shown a continued decline of 2.8% in US measured retail channels during the third quarter of 2025 year-to-date, raising concerns about future revenue performance in this area.

Colgate-Palmolive (CL) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 14 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Jan 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.